CLUSTER TECHNOLOGY CO., LTD.
4240・Standard Market・Chemicals
Other Businesses
A small-scale business outside the reportable segments, centered on foreign matter inspection for medical and pharmaceutical containers
| Period | Current | Previous | Change |
|---|---|---|---|
| Net sales (full year) | ¥10 million | ¥16 million | ↓ |
| Segment profit (full year) | ¥3 million | ¥2 million | ↑ |
| Segment assets | ¥0 million (¥284 thousand) | ¥0 million (¥654 thousand) | ↓ |
| Net sales YoY change | -35.5% | — | ↓ |
| Segment profit YoY change | +51.8% | — | ↑ |
Business Details
Other Businesses consists of operations utilizing the Company's core technologies (resin composite material technology, molding processing technology, measurement and analysis technology, etc.). The mainstay is the foreign matter inspection business for medical and pharmaceutical containers, which is a non-core business not included in the reportable segments. Its share of consolidated net sales is minor (approximately 0.8% for the full year of FY2026 (ending March 2026)). Segment assets represent an extremely small, asset-light service business.
Recent Overview
Net sales decreased significantly by 35.5% YoY to ¥10 million, but the profit margin improved
Full-year net sales of Other Businesses for FY2026 (ending March 2026) decreased significantly to ¥10 million (down 35.5% YoY). This reflects a reversal decline from the prior year (¥16 million). On the other hand, segment profit increased to ¥3 million (up 51.8% YoY), with the profit margin improving substantially. Despite the shrinking sales scale, profitability improved, likely aided by a decrease in low-margin projects, among other factors. Segment assets remained extremely minor at ¥284 thousand, and the asset-light nature of the business operations continues to be maintained.
Key Products
Growth Drivers
- Demand for foreign matter inspection of medical and pharmaceutical containers (seasonal demand for influenza treatment drugs, etc.)
- Differentiation through the utilization of the Company's core technology (measurement and analysis technology)
- Expansion of microfabrication technology applications in precision parts assembly
Risks
- Risk of sales and order volatility due to seasonality (dependent on factors such as influenza outbreak conditions)
- Extremely small business scale, with risk of dependence on a single customer or single product
- A significant decline of 35.5% YoY materialized in FY2026 (ending March 2026), reflecting high demand instability
- As a non-core business outside the reportable segments, it receives lower priority in management resource allocation
Last updated: June 30, 2026